NCT04820179 Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04814485 Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT04813432 Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas Status UNKNOWN Phase N/A
NCT04808362 Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours Status TERMINATED Phase PHASE1/PHASE2
NCT04807972 Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis Status TERMINATED Phase PHASE1
NCT04805307 Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 Status COMPLETED Phase PHASE1
NCT04803305 Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia Status COMPLETED Phase PHASE1
NCT04801095 A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT04783831 Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy Status UNKNOWN Phase N/A
NCT04764084 Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT04763642 The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone Status COMPLETED Phase NA
NCT04751435 Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients Status RECRUITING Phase NA
NCT04743479 Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) Status RECRUITING Phase N/A
NCT04731467 A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04683939 Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04683497 CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial Status UNKNOWN Phase NA
NCT04683315 PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples Status RECRUITING Phase PHASE2
NCT04682431 A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1